Groningen

• HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting
  2025-523717-29-00 5 2026-04-28 HFpEF or HFmrEF and obesity
• Optimization of pain management for acute renal colic in the Emergency Department – The OPTIMIZED trial Recruiting
  2025-521316-19-00 6 2026-04-20 Urolithiasis
• Neoadjuvant gemcitabine and cisplatin in combination with perioperative pembrolizumab versus upfront surgery for patients with primary resec … Recruiting
  2024-516898-72-00 10 2026-04-17 Perihilar cholangiocarcinoma, distal cholangiocarcinoma
• A trial to learn how safe the combination of rilvegostomig and chemotherapy is and how well it works compared to durvalumab and chemotherapy … Recruiting
  2025-523085-24-00 5 2026-04-13 Biliary Tract Cancer
• A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people Recruiting
  2025-525025-12-00 3 2026-04-10 Iron overload from thalassemia, transfusion-dependent myelodysplastic
• Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) Recruiting
  2025-523743-35-00 4 2026-04-07 Heart failure, cardiovascular disease, chronic kidney disease
• Phase 1 Single Ascending and Multiple Ascending Dose Study with LCA-0321 Recruiting
  2025-524053-14-00 1 2026-04-02 Graves Disease
• A phase I study investigating the local tolerability and pharmacokinetics of isoniazid (INH) inhalation by wet nebulization in patients with … Recruiting
  2024-517793-25-00 1 2026-03-30 Tuberculosis
• Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Previously Untreated, Unresectable, or Met … Recruiting
  2025-523224-45-00 10 2026-03-30 Untreated, Unresectable or Metastatic Colorectal Cancer
• Phase III Study of Rilvegostomig in Combination withBevacizumab with or without Tremelimumab as First-lineTreatment of Hepatocellular Carcin … Recruiting
  2024-518210-81-00 5 2026-03-18 Advanced Hepatocellular Carcinoma
• A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease Recruiting
  2025-524693-42-00 1 2026-03-09 Stable Coronary Artery Disease (CAD)
• A Phase 2 study to assess the safety and efficacy of SUL-238 in patients with early, untreated Parkinson’s Disease Recruiting
  2025-524674-42-00 4 2026-03-05 Parkinson’s Disease
• A Phase I study to evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects Recruiting
  2025-523108-59-00 1 2026-03-04 Severe infections caused by Gram-negative bacteria
• The PEARL trial: Prevention of hepatic Encephalopathy by administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoi … Recruiting
  2024-512040-28-01 6 2026-03-01 Confirmed diagnosis of Alcoholic liver cirrhosis
• method VALIDation and evaluation of non-radioactive methods to measure Glomerular Filtration Rate Recruiting
  2023-509156-34-02 6 2026-02-17 Chronic Kidney Disease Kidney Failure
• A research study to look at the distribution and effects of coramitug on amyloid deposits in heart tissue using PET/CT imaging in people wit … Recruiting
  2024-519372-22-00 3 2026-02-12 transthyretin amyloid amyloidosis cardiomyopathy (ATTR-CM)
• A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants Recruiting
  2025-524310-28-00 3 2026-02-02 Epilepsy, amotrophic lateral sclerosis, neuropathy
• Brivekimig for the treatment of moderate to severe hidradenitis suppurativa Recruiting
  2025-522333-61-00 4 2026-01-23 Hidradenitis suppurativa
• A Study of Amivantamab in Addition to Standard of Care Agents Compared with Standard of Care in Participants With Recurrent/Metastatic Head … Recruiting
  2025-521917-24-00 5 2026-01-21 Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
• A Single-Center, Double-Blind, Randomized, Placebo Controlled Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and P … Recruiting
  2025-523885-25-00 1 2026-01-21 Healthy Volunteers, Participants with diabetes and/or obesity
• IMCISION: Towards organ preservation and cure via ultra-short immunotherapy in advanced oral cancer. The IMCISION II trial, an investigator … Recruiting
  2025-522500-24-00 5 2026-01-20 Head and Neck squamous cell carcinoma
• A Phase 3 Study of JNT-517 in Participants with Phenylketonuria Recruiting
  2024-519554-37-00 5 2026-01-16 Phenylketonuria
• Evaluating PD-1/PD-L1 in rectal cancer by quantitative fluorescence molecular endoscopy. Recruiting
  2023-507106-13-00 1 2026-01-12 Locally advanced rectal cancer
• A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation Recruiting
  2025-520518-79-00 4 2026-01-06 Atrial Fibrillation

Showing 121–144 of 689 trials